Rating History for Ovid Therapeutics Inc (OVID) by Roth/MKM

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/19/2026 Boobalan Pachaiyappan Maintain Buy
(N/A)
5.00
(3.00)
 
 
  Details